Human fetal cartilage proteoglycan (PG) induces the development of an erosive polyarthritis and spondylitis in BALBIc mice. We have examined the properties of 3 monoclonal antibodies (MAb) to human fetal cartilage PG isolated from immunized mice that cross-react with mouse cartilage PG. Compared with sera from arthritic mice, which contain antibodies reactive with keratan sulfate, MAb 202 (IgG1) reacted only with a protein-related epitope that is distributed on both hyaluronic acid-binding and chondroitin sulfateattachment regions. MAb 813 (IgGl) Proteoglycan (PG) and collagen, which are major structural components of the extracellular matrix of articular cartilage, have been implicated in autoimmune mechanisms leading to the development and/or persistence of inflammatory diseases in humans, such as rheumatoid arthritis, ankylosing spondylitis, and relapsing polychondritis (1-7). The injection of type I1 collagen from cartilage produces polyarthritis in genetically predisposed strains of rats (8,9) and mice (10). Similarly, expression of immunity to cartilage PG in rabbits (1 1,12) and dogs (1 1) accompanies the development of inflammatory arthritis.Cellular immunity to cartilage PG has been observed in patients with ankylosing spondylitis (7,13) and rheumatoid arthritis (6,7). Female BALB/c mice develop a peripheral and axial polyarthritis when immunized intraperitoneally with human fetal PG in Freund's complete adjuvant (14). Clinical studies including radiographic and scintigraphic analyses have shown joint hypercapitation, progressive erosions, de-